Diagnostic Hospital Nuclear Medicine Radiopharmaceuticals 
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
AuntMinnie
APRIL 4, 2024
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added. Hope added.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 20, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
Open Medscience
NOVEMBER 4, 2023
Cyclotrons advance nuclear medicine by efficiently producing key radionuclides for diagnostics and treatment within hospital settings. The post The Pivotal Role of Cyclotrons in Radionuclide Production appeared first on Open Medscience.
Imaging Technology
JUNE 20, 2024
More than half of the world’s population is underserved and lacks access to essential health services, and two-thirds have no access to diagnostic imaging. In the hands of clinicians, these tools help make the practice of precision care more accessible and aim to help improve patient outcomes globally.”
AuntMinnie
JUNE 3, 2024
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
TTG Imaging Solutions
MAY 5, 2023
operates a diagnostic imaging turnkey business and serves as an OEM and service provider for a well-respected portfolio of fixed and mobile solid-state nuclear medicine cameras. Digirad has provided unique solutions to hospitals and outpatient providers for more than two decades. The acquisition closed on May 4, 2023.
Expert insights. Personalized for you.
122 
Let's personalize your content